SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-027538
Filing Date
2020-02-07
Accepted
2020-02-07 09:18:06
Documents
7
Period of Report
2020-02-07
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d879847d8k.htm 8-K 27240
2 EX-1.1 d879847dex11.htm EX-1.1 221588
3 EX-4.1 d879847dex41.htm EX-4.1 110824
4 EX-5.1 d879847dex51.htm EX-5.1 13608
5 EX-99.1 d879847dex991.htm EX-99.1 10773
6 GRAPHIC g879847g0205211139275.jpg GRAPHIC 3402
7 GRAPHIC g879847g0207101129951.jpg GRAPHIC 2533
  Complete submission text file 0001193125-20-027538.txt   393928
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 303-531-5952
MIRAGEN THERAPEUTICS, INC. (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36483 | Film No.: 20585004
SIC: 8071 Services-Medical Laboratories